...
首页> 外文期刊>Tetrahedron, Asymmetry: The International Journal for Repid Publication on all Aspects of Asymmetry in Orgainc, Inorganic, Organometallic, Physical and Bio-Organic Chemistry >An improved asymmetric synthetic route to a novel triple uptake inhibitor antidepressant (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H- pyran-4-ol (D-142)
【24h】

An improved asymmetric synthetic route to a novel triple uptake inhibitor antidepressant (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H- pyran-4-ol (D-142)

机译:新型三重吸收抑制剂抗抑郁药(2S,4R,5R)-2-苯甲基-5-((4-甲氧基苄基)氨基)四氢-2H-吡喃-4-醇(D-142)的改进的不对称合成途径

获取原文
获取原文并翻译 | 示例

摘要

Triple monoamine reuptake inhibitors have been implicated in the development of a new generation of antidepressants with higher efficacy than the currently existing therapies. In this paper, we have developed an alternative efficient synthetic route for triple monoamine reuptake inhibitor D-142 in 18.5% overall yield in 11 steps starting from diphenylmethane. D-142 was developed by us recently. The key step of the present synthetic strategy is the preferential formation of a bromohydrin from olefin via a cis-bromonium intermediate, which introduced significant efficiency in the overall synthesis. Furthermore, we have developed an efficient way to recycle the optically active intermediate diol back to the desired chiral epoxide.
机译:三联单胺再摄取抑制剂已涉及到新一代抗抑郁药的开发中,该抗抑郁药的功效比目前现有的疗法更高。在本文中,我们从二苯甲烷开始的11个步骤中,以18.5%的总收率开发了三重单胺再摄取抑制剂D-142的另一种有效合成途径。 D-142是我们最近开发的。本合成策略的关键步骤是通过顺式溴化铵中间体从烯烃优先形成溴代醇,这在整个合成过程中引入了显着的效率。此外,我们已经开发出一种有效的方法来将旋光中间体二醇再循环回所需的手性环氧化物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号